Antibiotic resistant bacteria are a threat to human lives, and yet the development of new drugs to treat bacterial infections is slow.
Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2 million (+6%) – Biotech Investments
EQS-News: aap Implantate AG / Key word(s): Sales Result Significant progress in all operating areas; stable fourth quarter leads to annual sales of EUR 12.2